The use of recombinant activated factor VII in platelet-associated bleeding

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Hematology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/102453308X315816PMID 18534065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization

  2006cited by this paper
• Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding

  2006cited by this paper
• Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia

  2006cited by this paper
• Use of rFVIIa in 4 Children With Glanzmann Thrombasthenia

  2006cited by this paper
• Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII

  2005cited by this paper
• Recombinant factor VIIa

  2005cited by this paper
• Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.

  2004cited by this paper
• Experiences with recombinant human factor VIIa in patients with thrombocytopenia.

  2004cited by this paper
• Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

  2004cited by this paper
• "Off-license" use of recombinant activated factor VII.

  2004cited by this paper
• Recombinant activated factor VII for non-hemophiliac bleeding patients

  2004cited by this paper
• The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics

  2004cited by this paper
• Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?

  2003cited by this paper
• The use of recombinant factor VIIa in children with inherited platelet function disorders

  2003cited by this paper
• Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.

  2003cited by this paper
• Mechanism of action of recombinant factor VIIa

  2003cited by this paper
• Use of Recombinant Factor VIIa for Bleeding in Children with Glanzmann Thrombasthenia

  2003cited by this paper
• Potential role for rFVIIa in transfusion medicine

  2002cited by this paper
• Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life‐threatening hemorrhage

  2002cited by this paper
• Activated Recombinant Factor VII (rFVIIa) in Bleeding Management after Therapy with llb/llla-Inhibitor Tirofiban

  2002cited by this paper
• Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa

  2002cited by this paper
• Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

  2002cited by this paper
• Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

  2001cited by this paper
• Recombinant Activated Factor VII (rFVIIa): Characterization, Manufacturing, and Clinical Development

  2001cited by this paper
• Off-label use of recombinant factor VIIa in patients following bone marrow transplantation

  2001cited by this paper
• Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.

  2000cited by this paper
• Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia

  2000cited by this paper
• Recombinant factor VIIa treatment of bleeding associated with acute renal failure.

  2000cited by this paper
• Use of Recombinant Factor VIIa in 3 Patients with Inherited Type I Glanzmann’s Thrombasthenia Undergoing Invasive Procedures

  2000cited by this paper
• New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.

  2000cited by this paper
• Recombinant activated factor VII (NovoSeven®) treatment of platelet‐related bleeding disorders

  2000cited by this paper
• Successful Epistaxis Control in a Patient with Glanzmann Thrombasthenia by Increased Bolus Injection Dose of Recombinant Factor VIIa

  1999cited by this paper
• Inherited Abnormalities of Platelets

  1999cited by this paper
• Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.

  1999cited by this paper
• Recombinant Factor VIIa in Severe Uremic Bleeding

  1998cited by this paper
• Assay of factor VIII antigen (VIII:CAg) in 294 Haemophilia A patients by a new commercial ELISA using monoclonal antibodies

  1998cited by this paper
• Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant Factor VIIa

  1998cited by this paper
• Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.

  1996cited by this paper
• A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.

  1996cited by this paper
• A Patient with Glanzmann Thrombasthenia and Epistaxis Successfully Treated with Recombinant Factor Vila

  1996cited by this paper

• Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase.

  2023cites this paper
• Adjuncts to Resuscitation

  2018cites this paper
• Damage Control Resuscitation

  2016cites this paper
• Acquired Hemostatic Disorders

  2015cites this paper
• Impedanzaggregometrische Analyse der Plättchenfunktion von Apherese-Thrombozytenkonzentraten in Abhängigkeit von der Lagerungsdauer

  2014cites this paper
• My patient is thrombocytopenic! Is (s)he? Why? And what shall I do?

  2013cites this paper
• Mein(e) PatientIn hat eine Thrombozytopenie! Ist es so? Warum? Und, was soll ich machen?

  2013cites this paper
• Inherited platelet disorders and oral health.

  2013cites this paper
• Disseminated Intravascular Coagulation in Burn Injury

  2010cites this paper
• Damage control resuscitation: the new face of damage control.

  2010cites this paper
• Disseminated intravascular coagulation in burn injury.

  2010cites this paper
• Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside.

  2009cites this paper
• Platelet function defects

  2008cites this paper